Pfizer and biontech to provide european union more than 200 million additional doses of comirnaty® to help meet continued need for vaccine supply

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced an agreement has been reached with the european commission (ec) and its member states to exercise an option to purchase more than 200 million additional doses of comirnaty®, the companies' covid-19 vaccine. contractual details are currently being finalized. these 200 million optional doses are in addition to the 450 million doses already planned to be delivered in 2022 based on pre
BNTX Ratings Summary
BNTX Quant Ranking